http://www.ft.com/companies/health en (PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1)) © Copyright The Financial Times Ltd 2013. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse. Fri, 24 May 2013 22:18:37 GMT Sat, 25 May 2013 20:45:30 GMT client.support@ft.com (Client Support) 15 Newspapers http://www.ft.com/rss/companies/health http://im.ft-static.com/m/img/rss/RSS_Default_Image.png http://www.ft.com/companies/health http://www.ft.com/cms/s/0/c489941e-c492-11e2-bc94-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct A price of $9bn would see the eyecare maker’s owner Warburg Pincus settle for less than its initial hopes of a sale topping $10bn Fri, 24 May 2013 22:18:37 GMT http://www.ft.com/cms/s/0/c489941e-c492-11e2-bc94-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct c489941e-c492-11e2-bc94-00144feab7de http://www.ft.com/cms/s/0/b4d1d20c-c488-11e2-bc94-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Dutch and UK institutions say they shared their findings with public health officials in more than 40 countries to accelerate diagnosis Fri, 24 May 2013 22:14:22 GMT http://www.ft.com/cms/s/0/b4d1d20c-c488-11e2-bc94-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct b4d1d20c-c488-11e2-bc94-00144feab7de http://www.ft.com/cms/s/3/684071b4-c3c0-11e2-8c30-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Shareholders can exchange $100 worth of the drugmaker’s stock for $108 of Zoetis stock and they can select which shares they wish to hold Thu, 23 May 2013 22:30:56 GMT http://www.ft.com/cms/s/3/684071b4-c3c0-11e2-8c30-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 684071b4-c3c0-11e2-8c30-00144feab7de http://www.ft.com/cms/s/0/2478906c-c3c3-11e2-8c30-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Legal action aimed against some of the pharma company’s former shareholders over a $500m regulatory fine Thu, 23 May 2013 21:33:22 GMT http://www.ft.com/cms/s/0/2478906c-c3c3-11e2-8c30-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 2478906c-c3c3-11e2-8c30-00144feab7de http://www.ft.com/cms/s/0/8eb985e0-c133-11e2-9767-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Data reveal extent of spending aimed at entertainment, consulting and research, which critics argue risks distorting the prescription of medicines Wed, 22 May 2013 19:53:03 GMT http://www.ft.com/cms/s/0/8eb985e0-c133-11e2-9767-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 8eb985e0-c133-11e2-9767-00144feab7de http://www.ft.com/cms/s/0/7dcc4eb6-c27d-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct UN experts say the H7N9 virus appears to have been brought under control in China due to restrictions at bird markets but caused huge losses to economy Wed, 22 May 2013 02:26:48 GMT http://www.ft.com/cms/s/0/7dcc4eb6-c27d-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 7dcc4eb6-c27d-11e2-ab66-00144feab7de http://www.ft.com/cms/s/0/4670a160-c232-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Doctors specialising in diseases of the central nervous system and mental disorders receive more money from drug companies than their counterparts Tue, 21 May 2013 22:44:41 GMT http://www.ft.com/cms/s/0/4670a160-c232-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 4670a160-c232-11e2-ab66-00144feab7de http://www.ft.com/cms/s/0/2fbd5a72-c222-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Criticism comes at a time when there is growing scrutiny over the use of the drug and questions about the quality of information on the product Tue, 21 May 2013 16:23:22 GMT http://www.ft.com/cms/s/0/2fbd5a72-c222-11e2-ab66-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 2fbd5a72-c222-11e2-ab66-00144feab7de http://www.ft.com/cms/s/3/a1678cf6-c173-11e2-b93b-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Acquisitive companies are opaque – there is tricky accounting involved and growth rates are hard to estimate. The new Actavis will be difficult to assess Mon, 20 May 2013 18:03:25 GMT http://www.ft.com/cms/s/3/a1678cf6-c173-11e2-b93b-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct a1678cf6-c173-11e2-b93b-00144feab7de http://www.ft.com/cms/s/0/41e8e9c2-c124-11e2-b93b-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Irish pharmaceutical group announces fresh debt and acquisition plans as Royalty steps up pressure on Elan with an improved $12.50-a-share cash offer Mon, 20 May 2013 17:01:52 GMT http://www.ft.com/cms/s/0/41e8e9c2-c124-11e2-b93b-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 41e8e9c2-c124-11e2-b93b-00144feab7de http://www.ft.com/cms/s/0/4d5df734-c147-11e2-9767-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct All-stock deal could bring an end to recent merger talks around Actavis and will create a speciality pharma group with an annual $11bn in sales Mon, 20 May 2013 15:53:21 GMT http://www.ft.com/cms/s/0/4d5df734-c147-11e2-9767-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 4d5df734-c147-11e2-9767-00144feab7de http://www.ft.com/cms/s/0/509dd604-c0a1-11e2-aa8e-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct The potential costs of global tax disputes by FTSE 100 companies fell by more than a third, suggesting a waning appetite for conflict Sun, 19 May 2013 23:03:41 GMT http://www.ft.com/cms/s/0/509dd604-c0a1-11e2-aa8e-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 509dd604-c0a1-11e2-aa8e-00144feab7de http://www.ft.com/cms/s/0/b1501ffa-bd6f-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Some awkward questions arise with new medical technology. Pre-emptive mastectomy is a procedure in which certain familiar distinctions break down Fri, 17 May 2013 18:18:02 GMT http://www.ft.com/cms/s/0/b1501ffa-bd6f-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct b1501ffa-bd6f-11e2-a735-00144feab7de http://www.ft.com/cms/s/0/99b617dc-be19-11e2-9b27-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Round-up of boardroom trading Fri, 17 May 2013 17:38:52 GMT http://www.ft.com/cms/s/0/99b617dc-be19-11e2-9b27-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 99b617dc-be19-11e2-9b27-00144feab7de http://www.ft.com/cms/s/0/0bb62e5c-be39-11e2-bb35-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Irish pharmaceutical group has turned down an offer from a US private equity group saying it was ‘grossly inadequate’ and a ‘misplaced or naive offer’ Thu, 16 May 2013 16:02:50 GMT http://www.ft.com/cms/s/0/0bb62e5c-be39-11e2-bb35-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 0bb62e5c-be39-11e2-bb35-00144feab7de http://www.ft.com/cms/s/0/642f1406-bd79-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Prof Sir Michael Rawlins’ move comes at a time of growing debate over the ‘revolving door’ between senior public and private sector posts Wed, 15 May 2013 22:38:00 GMT http://www.ft.com/cms/s/0/642f1406-bd79-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 642f1406-bd79-11e2-a735-00144feab7de http://www.ft.com/cms/s/0/6c3ebaa2-bd6a-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct In a pioneering study, researchers found malaria modifies mosquitoes’ sense of smell to make them nearly four times more attracted to humans Wed, 15 May 2013 21:05:39 GMT http://www.ft.com/cms/s/0/6c3ebaa2-bd6a-11e2-a735-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 6c3ebaa2-bd6a-11e2-a735-00144feab7de http://www.ft.com/cms/s/0/36c22356-b422-11e2-ace9-00144feabdc0.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Pharmaceutical companies fear that the battle raging in India over generic medicines will inspire emerging economies to change their patent laws Wed, 15 May 2013 19:12:36 GMT http://www.ft.com/cms/s/0/36c22356-b422-11e2-ace9-00144feabdc0.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 36c22356-b422-11e2-ace9-00144feabdc0 http://www.ft.com/cms/s/0/0af92ace-bcb2-11e2-9519-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct Human “therapeutic cloning” back on the scientific agenda as US-based team for the first time produce embryonic stem cells from those of adults Wed, 15 May 2013 16:33:01 GMT http://www.ft.com/cms/s/0/0af92ace-bcb2-11e2-9519-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 0af92ace-bcb2-11e2-9519-00144feab7de http://www.ft.com/cms/s/0/23eab2c0-bca6-11e2-9519-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct R&D enterprise seeks novel treatments for cancer and disorders of the nervous system and hopes to secure a licensing deal for ETS2101 by 2017 Tue, 14 May 2013 17:13:22 GMT http://www.ft.com/cms/s/0/23eab2c0-bca6-11e2-9519-00144feab7de.html?ftcamp=published_links%2Frss%2Fcompanies_health%2Ffeed%2F%2Fproduct 23eab2c0-bca6-11e2-9519-00144feab7de